Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Operating Expenses (2016 - 2025)

Dare Bioscience (DARE) has disclosed Operating Expenses for 11 consecutive years, with $3.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses fell 22.2% year-over-year to $3.7 million, compared with a TTM value of $17.4 million through Sep 2025, down 30.67%, and an annual FY2024 reading of $23.5 million, down 30.48% over the prior year.
  • Operating Expenses was $3.7 million for Q3 2025 at Dare Bioscience, down from $3.8 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $16.2 million in Q4 2022 and bottomed at $3.7 million in Q3 2025.
  • Average Operating Expenses over 5 years is $7.9 million, with a median of $7.7 million recorded in 2021.
  • The sharpest move saw Operating Expenses surged 80.85% in 2021, then plummeted 57.0% in 2023.
  • Year by year, Operating Expenses stood at $9.5 million in 2021, then soared by 70.08% to $16.2 million in 2022, then tumbled by 57.0% to $7.0 million in 2023, then dropped by 23.71% to $5.3 million in 2024, then plummeted by 30.99% to $3.7 million in 2025.
  • Business Quant data shows Operating Expenses for DARE at $3.7 million in Q3 2025, $3.8 million in Q2 2025, and $4.6 million in Q1 2025.